UBS Starts Coverage on Lodging Group: MAR, HOT, HST at Buy, CHH at Neutral
Tweet Send to a Friend
Get Alerts MAR Hot Sheet
Price: $42.77 +0.45%
Rating Summary:
15 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
15 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade MAR Now!
UBS initiated coverage on the Lodging group with a Positive outlook this morning. The firm sees RevPAR rising 3% this year.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
- Marriott (NYSE: MAR) - new Buy rating and $42 price target. The firm believes that Marriott currently offers an attractive risk/reward profile as it provides investors with exposure to managed and franchised hotels. UBS notes that with shares trading at about 12x forward-EBITDA, valuation is just below the stock's historical average.
- Starwood Hotels (NYSE: HOT) - new Buy rating and $60 price target. UBS likes that international operations are driving Starwood's current growth and that management is focused on owning premium assets.
- Host Hotels (NYSE: HST) - new Buy rating and $18 price target. The firm feels that Host's ownership model provides the strongest level of operating leverage of all the major lodging operators.
- Choice Hotels (NYSE: CHH) - new Neutral rating and $36 price target.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: A.G. Lafley Gives Procter & Gamble (PG) Investors 'New Hope', UBS Upgrades to Buy
- Topeka Capital Starts InvenSense (INVN) at Buy
- Deutsche Bank Starts Alnylam Pharmaceuticals (ALNY) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
UBSLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

